5 Value Stocks To Watch In The Healthcare Sector
Portfolio Pulse from Benzinga Insights
The article identifies five value stocks in the healthcare sector: Spok Holdings (SPOK), ABVC BioPharma (ABVC), BioNTech (BNTX), Akerna (KERN), and Quoin Pharmaceuticals (QNRX). These stocks are considered undervalued based on their low price-to-earnings (P/E) multiples. The article also provides updates on each company's recent earnings per share and notes that value stocks may take time to rebound from their undervalued positions.
August 28, 2023 | 2:45 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Quoin Pharmaceuticals reported earnings per share at $-2.13, up from $-4.08 in Q1.
The improvement in earnings per share indicates a better financial performance, which could attract investors and potentially drive the stock price up.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Spok Holdings reported Q2 earnings per share at $0.23, up by 53.33% from Q1. The company also reported a dividend yield of 10.82%, up by 0.99% from last quarter.
The increase in earnings per share and dividend yield indicates positive financial performance, which could attract investors and potentially drive the stock price up.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
ABVC BioPharma experienced a decrease in earnings per share from $-0.6 in Q1 to $-0.68 in the most recent quarter.
The decrease in earnings per share indicates a worsening financial performance, which could deter investors and potentially drive the stock price down.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
BioNTech reported earnings per share at $-0.86, down from $2.2 in Q1.
The significant drop in earnings per share indicates a negative financial performance, which could discourage investors and potentially drive the stock price down.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Akerna saw a decrease in earnings per share from -0.48 in Q1 to $-0.52 in the most recent quarter.
The decrease in earnings per share indicates a worsening financial performance, which could deter investors and potentially drive the stock price down.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100